(Q51537941)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

adverse prognostic factor

15 February 2020

main subject

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

3

Mats Jerkeman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Sari Riihijärvi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Minna Taskinen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

22 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Haematology

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

124-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

Follicular lymphoma international prognostic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

Glutathione-S-transferase genotypes influence the risk of chemotherapy-related toxicities and prognosis in Korean patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2010.01541.X

10.1111/J.1600-0609.2010.01541.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20942853%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference